Here we present the discovery of recurring lineage-restricted oncoproteins presented on MHC, focusing on immunotherapeutic targeting of the neuroblastoma CRC master regulator PHOX2B using PC-CARs. The gene discussed is HLA-C; the disease is neuroblastoma.